Perisorb™- Bioresorbable Peripheral Vascular Drug Eluting Stent System

A drug-eluting stent system designed for peripheral vascular applications. It provides structural support while releasing therapeutic agents to reduce restenosis in peripheral arteries.

Bioabsorbable sirolimus-eluting stent system designed for percutaneous coronary intervention (PCI) in coronary artery disease. The stent delivers sirolimus to inhibit neointimal hyperplasia while the polymer scaffold gradually resorbs, restoring vasomotor function. Indicated for patients with de novo coronary lesions requiring revascularization.

Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.

Drug-eluting stent for peripheral vascular interventions. Designed to expand narrowed peripheral vessels and maintain vessel patency.

Peripheral drug-eluting stent system for treatment of peripheral arterial disease with anti-restenosis drug coating.

A coronary stent coated with antiproliferative medication to reduce restenosis rates following percutaneous coronary intervention. Provides sustained drug delivery to the vessel wall over extended periods.

Interventional device for treating peripheral artery disease in lower extremities and other peripheral vessels. Restores blood flow in stenosed or occluded peripheral arteries.

A peripheral stent system eluting paclitaxel to treat stenotic lesions in lower extremity arteries. Provides mechanical support while delivering antiproliferative medication to prevent restenosis.

Biodegradable sinus stent for drug delivery and sinus cavity support. Naturally resorbs after healing without requiring surgical removal.

Drug-eluting coronary stent for percutaneous transluminal coronary angioplasty reducing restenosis in atherosclerotic lesions.

A coronary stent system designed to deliver therapeutic agents directly to arterial lesions, reducing restenosis rates in percutaneous coronary intervention procedures. Manufactured in Vietnam with proven clinical efficacy and biocompatibility.

MiStent® is a sirolimus-eluting coronary stent with absorbable polymer coating designed for percutaneous coronary intervention. The cobalt chromium alloy structure provides sustained radial support and fatigue resistance for treating coronary artery stenosis. The drug-eluting mechanism reduces neointimal proliferation while the absorbable polymer eliminates chronic inflammatory response after healing.